JP2015516420A5 - - Google Patents

Download PDF

Info

Publication number
JP2015516420A5
JP2015516420A5 JP2015511546A JP2015511546A JP2015516420A5 JP 2015516420 A5 JP2015516420 A5 JP 2015516420A5 JP 2015511546 A JP2015511546 A JP 2015511546A JP 2015511546 A JP2015511546 A JP 2015511546A JP 2015516420 A5 JP2015516420 A5 JP 2015516420A5
Authority
JP
Japan
Prior art keywords
optionally substituted
fluoro
pharmaceutically acceptable
acceptable salt
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015511546A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015516420A (ja
JP6178843B2 (ja
Filing date
Publication date
Priority claimed from PCT/CN2012/075185 external-priority patent/WO2013166654A1/en
Application filed filed Critical
Priority claimed from PCT/US2013/039377 external-priority patent/WO2013169576A1/en
Publication of JP2015516420A publication Critical patent/JP2015516420A/ja
Publication of JP2015516420A5 publication Critical patent/JP2015516420A5/ja
Application granted granted Critical
Publication of JP6178843B2 publication Critical patent/JP6178843B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015511546A 2012-05-08 2013-05-03 透過性グリコシダーゼインヒビターおよびその用途 Expired - Fee Related JP6178843B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
PCT/CN2012/075185 WO2013166654A1 (en) 2012-05-08 2012-05-08 Permeable glycosidase inhibitors and uses thereof
CNPCT/CN2012/075185 2012-05-08
US201261655641P 2012-06-05 2012-06-05
US61/655,641 2012-06-05
PCT/US2013/039377 WO2013169576A1 (en) 2012-05-08 2013-05-03 Permeable glycosidase inhibitors and uses thereof

Publications (3)

Publication Number Publication Date
JP2015516420A JP2015516420A (ja) 2015-06-11
JP2015516420A5 true JP2015516420A5 (https=) 2016-06-23
JP6178843B2 JP6178843B2 (ja) 2017-08-09

Family

ID=49551168

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015511546A Expired - Fee Related JP6178843B2 (ja) 2012-05-08 2013-05-03 透過性グリコシダーゼインヒビターおよびその用途

Country Status (10)

Country Link
US (1) US9611275B2 (https=)
EP (1) EP2847199B1 (https=)
JP (1) JP6178843B2 (https=)
KR (1) KR102108586B1 (https=)
CN (1) CN104395323B (https=)
AU (1) AU2013259892B2 (https=)
BR (1) BR112014027724B1 (https=)
CA (1) CA2871920C (https=)
RU (1) RU2707292C2 (https=)
WO (1) WO2013169576A1 (https=)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2321289A4 (en) 2008-08-01 2011-11-16 Univ Fraser Simon SELECTIVE GLYCOSIDASE HEMMER AND ITS USE
WO2011140640A1 (en) 2010-05-11 2011-11-17 Simon Fraser University Selective glycosidase inhibitors and uses thereof
US8933040B2 (en) 2010-11-08 2015-01-13 Craig A. Coburn Selective glycosidase inhibitors and uses thereof
RU2609210C2 (ru) 2010-12-23 2017-01-31 Алектос Терапьютикс Инк. Селективные ингибиторы гликозидазы и их применение
EP2688899B1 (en) 2011-03-24 2017-02-22 Alectos Therapeutics Inc. Selective glycosidase inhibitors and uses thereof
EP2691407B1 (en) 2011-03-31 2017-02-22 Alectos Therapeutics Inc. Selective glycosidase inhibitors and uses thereof
US9701693B2 (en) 2011-06-27 2017-07-11 Alectos Therapeutics Inc. Selective glycosidase inhibitors and uses thereof
BR112013033098B8 (pt) 2011-06-27 2021-03-23 Alectos Therapeutics Inc inibidores de glicosidade seletivos e usos dos mesmos
EP2726468B1 (en) 2011-06-27 2017-04-12 Alectos Therapeutics Inc. Selective glycosidase inhibitors and uses thereof
EP2890676B1 (en) 2012-08-31 2018-12-05 Alectos Therapeutics Inc. Glycosidase inhibitors and uses thereof
EP2890675A4 (en) 2012-08-31 2016-01-13 Alectos Therapeutics Inc GLYCOSIDASE INHIBITORS AND USES THEREOF
KR20150079711A (ko) 2012-10-31 2015-07-08 알렉토스 테라퓨틱스 인크. 글리코시다아제 저해제 및 이의 용도
WO2014100934A1 (en) 2012-12-24 2014-07-03 Merck Sharp & Dohme Corp. Glycosidase inhibitors and uses thereof
SG11201510177WA (en) 2013-06-11 2016-01-28 Harvard College SC-β CELLS AND COMPOSITIONS AND METHODS FOR GENERATING THE SAME
SG11201703148TA (en) 2014-11-05 2017-05-30 Voyager Therapeutics Inc Aadc polynucleotides for the treatment of parkinson's disease
CN119876138A (zh) 2014-11-14 2025-04-25 沃雅戈治疗公司 调节性多核苷酸
CA3024448C (en) 2016-05-18 2025-09-09 Voyager Therapeutics, Inc. MODULATING POLYNUCLEOTIDES
CA3024449A1 (en) 2016-05-18 2017-11-23 Voyager Therapeutics, Inc. Compositions and methods of treating huntington's disease
JP2020518259A (ja) 2017-05-05 2020-06-25 ボイジャー セラピューティクス インコーポレイテッドVoyager Therapeutics,Inc. ハンチントン病治療組成物および方法
JOP20190269A1 (ar) 2017-06-15 2019-11-20 Voyager Therapeutics Inc بولي نوكليوتيدات aadc لعلاج مرض باركنسون
SG11202011296VA (en) 2018-05-15 2020-12-30 Voyager Therapeutics Inc Compositions and methods for the treatment of parkinson's disease
CN109160873A (zh) * 2018-08-14 2019-01-08 重庆市化工研究院 一种芳香族烯丙基醚及其合成方法和应用
EP4217360A4 (en) * 2020-09-25 2024-08-21 Universidad de Sevilla (US) - University of Seville (US) GLYCOSIDASE INHIBITORS AND THEIR USES

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1441749A1 (ru) * 1987-03-16 1996-01-10 Институт Тонкой Органической Химии Им.А.Л.Мнджояна 2-АМИНО-5,5-ДИМЕТИЛ-4,5-ДИГИДРО-7Н-ПИРАНО [4,3-d] ТИАЗОЛ, ОБЛАДАЮЩИЙ ТРАНКВИЛИЗИРУЮЩЕЙ АКТИВНОСТЬЮ
WO2006016904A2 (en) 2004-04-14 2006-02-16 Uab Research Foundation Activators of hexosamine biosynthesis as inhibitors of injury induced by ischemia or hemorrhagic shock
CA2599843C (en) 2005-03-01 2013-08-27 Simon Fraser University Selective glycosidase inhibitors, methods of making inhibitors, and uses thereof
CN107253970A (zh) * 2006-08-31 2017-10-17 西蒙·弗雷瑟大学 选择性糖苷酶抑制剂及其用途
AU2007291870B2 (en) * 2006-08-31 2012-12-06 Simon Fraser University Selective glycosidase inhibitors and uses thereof
CA2732335A1 (en) 2008-08-01 2010-02-04 Simon Fraser University Selective glycosidase inhibitors and uses thereof
EP2321289A4 (en) 2008-08-01 2011-11-16 Univ Fraser Simon SELECTIVE GLYCOSIDASE HEMMER AND ITS USE
CA2737267A1 (en) 2008-09-16 2010-04-08 Simon Fraser University Selective glycosidase inhibitors and uses thereof
WO2011140640A1 (en) * 2010-05-11 2011-11-17 Simon Fraser University Selective glycosidase inhibitors and uses thereof
WO2012061972A1 (en) 2010-11-08 2012-05-18 Alectos Therapeutics Inc. Selective glycosidase inhibitors and uses thereof
TW201249848A (en) * 2010-11-08 2012-12-16 Merck Sharp & Dohme Selective glycosidase inhibitors and uses thereof
WO2012159262A1 (en) * 2011-05-24 2012-11-29 Alectos Therapeutics Inc. Selective glycosidase inhibitors and uses thereof
US9126957B2 (en) 2011-08-18 2015-09-08 Merck Sharp & Dohme Corp. Selective glycosidase inhibitors and uses thereof

Similar Documents

Publication Publication Date Title
JP2015516420A5 (https=)
RU2014149183A (ru) Проницаемые ингибиторы гликозидазы и их применения
JP2013533253A5 (https=)
JP2012510502A5 (https=)
PE20230834A1 (es) Antagonistas del receptor de lpa y usos de los mismos
JP2013525458A5 (https=)
EP4328223A3 (en) Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith
EA201590345A1 (ru) Способы лечения рака с использованием 3-(4-((4-(морфолинометил)бензил)окси)-1-оксоизоиндолин-2-ил)пиперидин-2,6-диона
JP2011517453A5 (https=)
NZ631477A (en) Substituted pyrrolidine-2-carboxamides
RU2014125230A (ru) Пиридонамиды и их аналоги, демонстрирующие противораковую и антипролиферативную активность
JP2020527175A5 (https=)
JP2013523733A5 (https=)
PH12014500775A1 (en) Ethynyl derivatives as mglur5 allosteric modulators
JP2013536188A5 (https=)
RU2013140169A (ru) Противоопухолевое терапевтическое средство
MX2013009709A (es) Derivados de heteroarilo como moduladores de nachr alfa 7.
PH12013501895A1 (en) Ethynyl derivatives as positive allosteric modulators of the mglur5
JP2012518634A5 (https=)
JP2013542267A5 (https=)
BR112013021848A2 (pt) 5-(fenil/piridinil-etinil)-2-piridina/2-pirimidina-carboxamidas como moduladores de mglur5
JP2014505017A5 (https=)
MX2016008536A (es) Derivados de fluoro-naftilo.
JP2017502063A5 (https=)
MX2009013115A (es) Derivados de prolinamida como antagonistas de nk3.